Infection, mutation, and cancer evolution

Journal of Molecular Medicine

Volumn 90, Issue 5, 2012, Pages 535-541

  Ewald, Paul W ^a   Ewald, Holly A Swain ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Apoptosis; Cancer evolution; Cell cycle arrest; EBV; Evolution; Hepatitis B; Hepatitis C; HTLV; Infection; KSHV; Mutation; Natural selection; Oncogenesis; Oncogenic selection; Papillomavirus; Telomerase

Indexed keywords

CYCLIN DEPENDENT KINASE 6; CYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; LATENT MEMBRANE PROTEIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN; SURVIVIN; TAX PROTEIN; TELOMERASE; VIRUS PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; APOPTOSIS; BILE DUCT CARCINOMA; BRAIN CANCER; BREAST CANCER; BURKITT LYMPHOMA; CANCER MORTALITY; CARCINOGENESIS; CELL CYCLE ARREST; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CYTOMEGALOVIRUS; DISEASE TRANSMISSION; DNA SYNTHESIS; EPSTEIN BARR VIRUS; ESOPHAGUS CANCER; EVOLUTION; FLAVIVIRUS; GENETIC DAMAGE; HEPADNAVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOST SUSCEPTIBILITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; KAPOSI SARCOMA; MERKEL CELL CANCER; MERKEL CELL POLYOMAVIRUS; MOLECULAR MECHANICS; MOUSE MAMMARY TUMOR ONCOVIRUS; MUTATION; NASOPHARYNX CANCER; NATURAL SELECTION; NEOPLASM; NONHUMAN; ONCOGENIC SELECTION; OROPHARYNX CANCER; OVARY CANCER; PENIS CANCER; PROTEIN BINDING; RECTUM CANCER; RETROVIRUS; REVIEW; SALIVA; SEXUALLY TRANSMITTED DISEASE; STOMACH CARCINOMA; T CELL LEUKEMIA; TUMOR VIRUS; UTERINE CERVIX CANCER; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; WART VIRUS;

ANIMALS; BIOLOGICAL EVOLUTION; HUMANS; INFECTION; MUTATION; NEOPLASMS; ONCOGENIC VIRUSES; SELECTION, GENETIC;

EID: 84862524885     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0891-2     Document Type: Review

References (55)

1. Aktipis CA, Maley CC, Pepper JW (2012) Dispersal evolution in neoplasms: the role of dysregulated metabolism in the evolution of cell motility. Cancer Prev Res (Phila) 5:266-275
2. Arora P, Kim EO, Jung JK, Jang KL (2008) Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett 261:244-252
3. Banerjee P, Feuer G, Barker E (2007) Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J Virol 81:9707-9717
4. Cai Q, Guo Y, Xiao B, Banerjee S, Saha A, Lu J, Glisovic T, Robertson ES (2011) Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis. PLoS Pathog 7:e1002418
5. Cai Q, Verma SC, Lu J, Robertson ES (2010) Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res 78:87-142
6. Chen J, Sprouffske K, Huang Q, Maley CC (2011) Solving the puzzle of metastasis: the evolution of cell migration in neoplasms. PLoS One 6:e17933
7. Chen L, Hu L, Li L, Liu Y, Tu QQ, Chang YX, Yan HX, Wu MC, Wang HY (2010) Dysregulation of beta-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas. Front Med China 4:399-411
8. Choi YH, Kim HI, Seong JK, Yu DY, Cho H, Lee MO, Lee JM, Ahn YH, Kim SJ, Park JH (2004) Hepatitis B virus X protein modulates peroxisome proliferator-activated receptor gamma through protein-protein interaction. FEBS Lett 557:73-80
9. Ding L, Li L, Yang J, Zhou S, Li W, Tang M, Shi Y, Yi W, Cao Y (2007) Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways. J Med Virol 79:1153-1163
10. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937
11. Dyson OF, Oxendine TL, Hamden KE, Ford PW, Akula SM (2008) Differential regulation of the attachment of Kaposi's sarcoma-associated herpesvirus (KSHV)-infected human B cells to extracellular matrix by KSHV-encoded gB and cellular alphaV integrins. Cell Microbiol 10:1546-1558
12. Ewald PW (2009) An evolutionary perspective on parasitism as a cause of cancer. Adv Parasitol 68:21-43
13. Gewin L,Myers H, Kiyono T, Galloway DA (2004) Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev 18:2269-2282
14. Guasparri I, Bubman D, Cesarman E (2008) EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111:3813-3820
15. Higgs MR, Lerat H, Pawlotsky JM (2010) Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res 70:4901-4911
16. Hino R, Uozaki H, Inoue Y, Shintani Y, Ushiku T, Sakatani T, Takada K, Fukayama M (2008) Survival advantage of EBVassociated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Cancer Res 68:1427-1435
17. Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K et al (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69:2766-2774
18. Huang XH, Sun LH, Lu DD, Sun Y,Ma LJ, Zhang XR, Huang J, Yu L (2003) Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. World J Gastroenterol 9:692-695
19. Jiang J, Zhao LJ, Zhao C, Zhang G, Zhao Y, Li JR, Li XP, Wei LH (2012) Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells. Gynecol Oncol 124(3):534-541
20. Katzenellenbogen RA, Egelkrout EM, Vliet-Gregg P, Gewin LC, Gafken PR, Galloway DA (2007) NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells. J Virol 81:3786-3796
21. Kew MC (2011) Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol 26(Suppl 1):144-152
22. Kim YM, Geiger TR, Egan DI, Sharma N, Nyborg JK (2010) The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription. Oncogene 29:2142-2152
23. Kirk GD, Camus-Randon AM, Mendy M, Goedert JJ, Merle P, Trepo C, Brechot C, Hainaut P, Montesano R (2000) Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst 92:148-153
24. Knight J, Sharma N, Robertson E (2005) Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiqitin ligase. PNAS 102:18562-18566
25. Li ZH, Tang QB, Wang J, Zhou L, Huang WL, Liu RY, Chen RF (2010) Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factorkappaB pathway. J Gastroenterol Hepatol 25:1315-1320
26. Limpaiboon T, Pooart J, Bhattarakosol P, Niruthisard S, Chantratita W, Lulitanond V (2000) p53 status and human papillomavirus infection in Thai women with cervical carcinoma. Southeast Asian J Trop Med Public Health 31:66-71
27. Liu H, Luan F, Ju Y, Shen H, Gao L,Wang X, Liu S, Zhang L, Sun W, Ma C (2007) In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase. Biochem Biophys Res Commun 355:379-384
28. Liu WK, Chu YL, Zhang F, Chen P, Cheng F,Wang H, Jia YY, Ma TY (2005) The relationship between HPV16 and expression of CD44v6, nm23H1 in esophageal squamous cell carcinoma. Arch Virol 150:991-1001
29. Liu YC, Chen CJ,Wu HS, Chan DC, Yu JC, Yang AH, Cheng YL, Lee SC, Harn HJ (2004) Telomerase and c-myc expression in hepatocellular carcinomas. Eur J Surg Oncol 30:384-390
30. Luan F, Liu H, Gao L, Liu J, Sun Z, Ju Y, Hou N, Guo C, Liang X, Zhang L et al (2009) Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Gut 58:1528-1537
31. Medema RH, Klompmaker R, Smits VA, Rijksen G (1998) p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene 16:431-441
32. Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6:924-935
33. Mileo AM, Piombino E, Severino A, Tritarelli A, Paggi MG, Lombardi D (2006) Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein. J Bioenerg Biomembr 38:215-225
34. Moore PS (2007) KSHV manipulation of the cell cycle and apoptosis. In: Arvin A et al (eds) Human herpesviruses biology, therapy, and immunoprophylaxis, p (online book; http://www.ncbi.nlm.nih.gov/books/NBK47432/) Cambridge University Press, Cambridge
35. Moss SF, Blaser MJ (2005) Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2:90-97, quiz 91 p following 113
36. Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Brechot C, Paterlini-Brechot P (2005) Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54:1162-1168
37. Parroche P, ToukaM,Mansour M, Bouvard V, Thepot A, Accardi R, Carreira C, Roblot GG, Sylla BS, Hasan U et al (2011) Human papillomavirus type 16 E6 inhibits p21(WAF1) transcription independently of p53 by inactivating p150(Sal2). Virology 417:443-448
38. Paterlini-Brechot P, Saigo K, Murakami Y, Chami M, Gozuacik D, Mugnier C, Lagorce D, Brechot C (2003) Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22:3911-3916
39. Portis T, Longnecker R (2004) Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23:8619-8628
40. Saha A, Bamidele A, Murakami M, Robertson ES (2011) EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5. J Virol 85:2079-2088
41. Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES (2009) Epstein-Barr virus nuclear antigen 3 C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J Virol 83:4652-4669
42. Sieburg M, Tripp A, Ma JW, Feuer G (2004) Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis. J Virol 78:10399-10409
43. Sinha-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, Kazanji M, Barrett JC, Nicot C (2004) Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood 104:2523-2531
44. Sprouffske K, Pepper JW, Maley CC (2011) Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res (Phila) 4:1135-1144
45. Stearns SC, Nesse RM, Haig D (2008) Introducing evolutionary thinking for medicine. In: Stearns SC, Koella JC (eds) Evolution in health and disease. Oxford University Press, New York
46. Su JM, Lai XM, Lan KH, Li CP, Chao Y, Yen SH, Chang FY, Lee SD, Lee WP (2007) X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter. Hepatology 46:402-413
47. Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, Zehbe I (2003) The role of TP53 in cervical carcinogenesis. Hum Mutat 21:307-312
48. Trevathan WR, Smith EO, McKenna JJ (2008) Introduction and overview of evolutionary medicine. In: Trevathan WR et al (eds) Evolutionary medicine and health. Oxford University Press, New York, pp 1-54
49. Tsai WL, Chung RT (2010) Viral hepatocarcinogenesis. Oncogene 29:2309-2324
50. Tungteakkhun SS, Duerksen-Hughes PJ (2008) Cellular binding partners of the human papillomavirus E6 protein. Arch Virol 153:397-408
51. Verma SC, Borah S, Robertson ES (2004) Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus upregulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J Virol 78:10348-10359
52. Williams GC, Nesse RM (1991) The dawn of Darwinian medicine. Q Rev Biol 66:1-22
53. Xu M, Katzenellenbogen RA, Grandori C, Galloway DA (2010) NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity. J Virol 84:11461-11469
54. Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES (2009) Epstein-Barr virus nuclear antigen 3 C targets p53 and modulates its transcriptional and apoptotic activities. Virology 388:236-247
55. Zhang X, Dong N, Zhang H, You J, Wang H, Ye L (2005) Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med 145:98-104